GlassScriptPhysician profile
Cheryl A Jacobs
NPI 1790939924
$2,462.57
in general payments reported to CMS, 2019-2025
13 companies · $267 in 2025
The $267 reported for 2025 was more than what 82% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $611 · 2023: $894 · 2024: $155 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.94 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,240.97 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $383.38 | 2022-2024 | Jornay Pm |
| Corium, LLC | $364.45 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $96.36 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $87.42 | 2023 | |
| Kaleo, INC. | $69.28 | 2021-2023 | Auvi-Q |
| Takeda Pharmaceuticals U.S.A., INC. | $67.00 | 2021-2022 | |
| Glaxosmithkline, LLC. | $45.76 | 2022-2025 | Bexsero, Penmenvy |
| Collegium Pharmaceutical, INC. | $31.08 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $23.31 | 2025 | Neffy |
| Tris Pharma INC | $21.58 | 2025 | Dyanavel Xr |
| Ultragenyx Pharmaceutical INC. | $18.49 | 2021 | |
| Adlon Therapeutics L.P. | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.